Literature DB >> 20854475

Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.

Soon Deok Park1, Young Uh, Gyusang Lee, Kwanhun Lim, Jong Bae Kim, Seok Hoon Jeong.   

Abstract

A total of 100 clinical isolates of Escherichia coli (n = 35), Klebsiella pneumoniae (n = 63), Proteus mirabilis (n = 1), and Salmonella serovar Stanley (n = 1), showing resistance to cefoxitin, or returning positive in extended-spectrum β-lactamase (ESBL) by Clinical and Laboratory Standards Institute (CLSI) ESBL confirmatory method, were studied. The isolates were examined by the boronic acid (BA) disk test, polymerase chain reaction, and pulsed-field gel electrophoresis (PFGE) to investigate genetic similarities. The concurrence rates for ESBLs by the CLSI and the BA disk test were 97% for E. coli and 96.7% for K. pneumoniae. A total of 41 isolates showing cefoxitin resistance yielded all positive by the BA disk test. All the 33 K. pneumoniae isolates, which showed positive by the BA disk test, were carrying AmpC genes. The TEM and CTX-M types were predominant in E. coli and the SHV and the CIT and/or DHA types were predominant in K. pneumoniae. PFGE analysis showed almost 75% of genetic similarities among K. pneumoniae isolates producing ESBLs and/or AmpC β-lactamases (AmpCs) as each K. pneumoniae carried variable genes and showed variable antibiotic patterns. Clearly, the BA disk test was a useful method for the detection of ESBLs and AmpCs. In particular, cefoxitin resistance and BA-positive trait of K. pneumoniae do reflect the presence of AmpC genes in the organism.
© 2010 The Authors. Journal Compilation © 2010 APMIS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854475     DOI: 10.1111/j.1600-0463.2010.02663.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  4 in total

1.  Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.

Authors:  Xiaoli Cao; Lina M Cavaco; Yuan Lv; Yun Li; Bo Zheng; Pengyuan Wang; Henrik Hasman; Yucun Liu; Frank M Aarestrup
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

2.  Multidrug resistant AmpC β-lactamase producing Escherichia coli isolated from a paediatric hospital.

Authors:  Noor-Ul-Ain Jameel; Hasan Ejaz; Aizza Zafar; Hafsa Amin
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

3.  Development of a Rapid Reverse Blot Hybridization Assay for Detection of Clinically Relevant Antibiotic Resistance Genes in Blood Cultures Testing Positive for Gram-Negative Bacteria.

Authors:  Hye-Young Wang; Gilsung Yoo; Juwon Kim; Young Uh; Wonkeun Song; Jong Bae Kim; Hyeyoung Lee
Journal:  Front Microbiol       Date:  2017-02-09       Impact factor: 5.640

4.  The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.

Authors:  Jin Young Ahn; Hea Won Ann; Yongduk Jeon; Mi Young Ahn; Dong Hyun Oh; Yong Chan Kim; Eun Jin Kim; Je Eun Song; In Young Jung; Moo Hyun Kim; Wooyoung Jeong; Nam Su Ku; Su Jin Jeong; Jun Yong Choi; Dongeun Yong; Young Goo Song; June Myung Kim
Journal:  BMC Infect Dis       Date:  2017-05-03       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.